Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Lux

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|February 23, 2024
Oriented display of HIV-1 Env trimers by a novel coupling strategy enhances B cell activation and phagocytosisRiccardo Di Vincenzo, Jannis Beutel, Philipp Arnold, et al.
European Journal of Immunology|December 28, 2021
B-cell modulation with anti-CD79b antibodies ameliorates experimental autoimmune encephalitis in miceKerstin Renner, Sophia Neumayer, Yvonne Talke, et al.
Haematologica|June 6, 2020
Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapyKatja Klausz, Michael Cieker, Christian Kellner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 20, 2019
Fra1 Controls Rheumatoid Factor Autoantibody Production by Bone Marrow Plasma Cells and the Development of Autoimmune Bone LossBettina Grötsch, Anja Lux, Yoann Rombouts, et al.
The Journal of Biological Chemistry|January 9, 2009
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5Effi Wies, Alexander S Hahn, Katharina Schmidt, et al.
Immunity|February 15, 2015
Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infectionDouglas H Yamada, Heidi Elsaesser, Anja Lux, et al.
Cell Reports|April 2, 2014
A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activityAnja Lux, Michaela Seeling, Anne Baerenwaldt, et al.
New Biotechnology|November 29, 2024
An industrial-grade Nicotiana benthamiana line for the production of glycoproteins carrying fucose-free galactosylated N-glycansBenjamin Kogelmann, Stanislav Melnik, Tahereh Keshvari, et al.
Frontiers in Immunology|January 31, 2020
Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations <i>in vivo</i>Anja Schaffert, Maja Hanić, Mislav Novokmet, et al.
Frontiers in Immunology|November 8, 2024
IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacySomanath Kallolimath, Lin Sun, Roman Palt, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|February 23, 2024
Oriented display of HIV-1 Env trimers by a novel coupling strategy enhances B cell activation and phagocytosisRiccardo Di Vincenzo, Jannis Beutel, Philipp Arnold, et al.
European Journal of Immunology|December 28, 2021
B-cell modulation with anti-CD79b antibodies ameliorates experimental autoimmune encephalitis in miceKerstin Renner, Sophia Neumayer, Yvonne Talke, et al.
Haematologica|June 6, 2020
Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapyKatja Klausz, Michael Cieker, Christian Kellner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 20, 2019
Fra1 Controls Rheumatoid Factor Autoantibody Production by Bone Marrow Plasma Cells and the Development of Autoimmune Bone LossBettina Grötsch, Anja Lux, Yoann Rombouts, et al.
The Journal of Biological Chemistry|January 9, 2009
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5Effi Wies, Alexander S Hahn, Katharina Schmidt, et al.
Immunity|February 15, 2015
Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infectionDouglas H Yamada, Heidi Elsaesser, Anja Lux, et al.
Cell Reports|April 2, 2014
A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activityAnja Lux, Michaela Seeling, Anne Baerenwaldt, et al.
New Biotechnology|November 29, 2024
An industrial-grade Nicotiana benthamiana line for the production of glycoproteins carrying fucose-free galactosylated N-glycansBenjamin Kogelmann, Stanislav Melnik, Tahereh Keshvari, et al.
Frontiers in Immunology|January 31, 2020
Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations <i>in vivo</i>Anja Schaffert, Maja Hanić, Mislav Novokmet, et al.
Frontiers in Immunology|November 8, 2024
IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacySomanath Kallolimath, Lin Sun, Roman Palt, et al.
Pageof 7